XML 20 R9.htm IDEA: XBRL DOCUMENT v3.24.3
Note 2 - Fair Value of Financial Instruments
9 Months Ended
Sep. 30, 2024
Notes to Financial Statements  
Fair Value Disclosures [Text Block]

2. Fair Value of Financial Instruments

 

The estimated fair values of the Company’s financial instruments, which include cash equivalents, accounts receivable, accounts payable and other accrued liabilities, approximate their carrying values due to the short-term nature of these instruments. The Company’s marketable securities are classified as available-for-sale and are reported at fair value. Unrealized holding gains and losses are excluded from earnings and are reported net of tax in “accumulated other comprehensive loss” in the Consolidated Balance Sheets until realized. Realized gains and losses are included in “other income, net” in the Consolidated Statements of Operations and are derived using the specific identification method for determining the cost of marketable securities sold.

  

The Companys fair value hierarchy for its cash equivalents and marketable securities was as follows:

 

September 30, 2024

 

Level 1

  

Level 2

  

Level 3

  

Total

 

Money market securities

 $2,853  $  $  $2,853 

Commercial paper

     14,227      14,227 

Federal agency notes

     13,454      13,454 

U.S. treasuries

     2,489      2,489 

Total

 $2,853  $30,170  $  $33,023 

 

December 31, 2023

 

Level 1

  

Level 2

  

Level 3

  

Total

 

Money market securities

 $1,515  $  $  $1,515 

Commercial paper

     14,622      14,622 

U.S. treasuries

     5,953      5,953 

Federal agency notes

     998      998 

Total

 $1,515  $21,573  $  $23,088 

 

The fair value maturities of the Company’s cash equivalents and marketable securities as of September 30, 2024, were as follows:

 

  

Maturities by Period

 
      

Less than

  

1-5

  

5-10

  

More than

 
  

Total

  

1 year

  

years

  

years

  

10 years

 

Cash equivalents and marketable securities

 $33,023  $33,023  $  $  $ 

 

The Company considers all highly liquid marketable securities with original maturities of 90 days or less at the date of acquisition to be cash equivalents. Cash equivalents include commercial paper, federal agency notes, U.S. treasuries, and money market securities totaling $24,897 and $17,362 at  September 30, 2024 and December 31, 2023, respectively. Cash equivalents are carried at either cost or fair value, depending on the type of security.